Skip to main content

Table 1 Profile of patients at baseline

From: MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy

Patients, number

161

  

Male/female, number

40/121

  

Age, years

57.4 ± 12.2

(median 58)

n = 161

Onset age, years

53.0 ± 12.4

(median 54)

n = 161

Disease duration, years

4.4 ± 6.9

(median 1.4)

n = 161

Methotrexate used, number of patients (%)

161 (100)

 

n = 161

Baseline methotrexate dose, mg/wk

4.3 ± 0.9

(median 4)

n = 161

Prednisolone used, number (%)

38 (23.6)

 

n = 38

Baseline prednisolone dose, mg/day

5.0 ± 3.2

 

n = 38

Baseline prednisolone dose, mg/day

1.2 ± 2.6

(median 0)

n = 161

Conventional disease-modifying anti-rheumatic drugs used, number of patients (%)

73 (45.3)

 

n = 161

Stage 1

73

45.3 %

 

Stage 2

42

26.1 %

 

Stage 3

28

17.4 %

 

Stage 4

18

11.2 %

 

Class I

78

48.4 %

 

Class II

76

47.2 %

 

Class III

7

4.3 %

 

Class IV

0

0.0 %

 

C-reactive protein, mg/dl

2.6 ± 3.0

(median 1.5)

n = 161

Erythrocyte sedimentation rate, mm/h

55.1 ± 35.1

(median 48)

n = 161

Tender joint count

7.1 ± 5.7

(median 6)

n = 161

Swollen joint count

7.5 ± 5.4

(median 7)

n = 161

Disease activity score in 28 joints-C-reactive protein (4)

4.8 ± 1.1

(median 4.6)

n = 129

Disease activity score in 28 joints-erythrocyte sedimentation rate (4)

5.5 ± 1.2

(median 5.5)

n = 129

Disease activity score in 28 joints-C-reactive protein (3)

4.5 ± 1.0

(median 4.3)

n = 161

Disease activity score in 28 joints-erythrocyte sedimentation rate (3)

5.2 ± 1.1

(median 5.2)

n = 161

Visual analog scale, mm

52.4 ± 28.0

(median 51)

n = 129

Matrix metalloproteinase-3, ng/ml

241.9 ± 304.2

(median 133)

n = 157

Rheumatoid factor

119.2 ± 226.5

(median 45.3)

n = 157

Morning stiffness, minutes

165.6 ± 362.6

(median 35)

n = 158

Grip strength, (L+ R)/2 mmHg

176.8 ± 66.7

(median 171)

n = 157

Modified health assessment questionnaire

0.543 ± 0.469

(median 0.500)

n = 130

Baseline van der Heijde modified total Sharp score

18.6 ± 33.2

(median 4.0)

n = 161

Baseline van der Heijde modified total Sharp score, progression, –1 to 0 years

7.9 ± 19.0

(median 3.0)

n = 161